help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 3, 2008
Endocrinology, doi:10.1210/en.2007-1387
A more recent version of this article appeared on July 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/7/3708    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TANCEVSKI, I.
Right arrow Articles by RITSCH, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TANCEVSKI, I.
Right arrow Articles by RITSCH, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL

Submitted on October 15, 2007
Accepted on March 24, 2008

Reduced Plasma HDL Cholesterol in Hyperthyroid Mice Coincides with Decreased Hepatic ABCA1 Expression

IVAN TANCEVSKI*, ANDREAS WEHINGER, EGON DEMETZ, PHILIPP ELLER, KRISTINA DUWENSEE, JULIA HUBER, KATHRIN HOCHEGGER, WILFRIED SCHGOER, CATHERINE FIEVET, FRANS STELLAARD, MATS RUDLING, JOSEF R. PATSCH, and ANDREAS RITSCH

From the Department of Internal Medicine, Innsbruck Medical University, Innsbruck, Austria; Département d'Athérosclérose, Institut Pasteur de Lille, Lille Cedex, France; Laboratory of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, University Medical Center Groningen, Groningen, The Netherlands; Karolinska Institute at Center for Endocrinology, Metabolism and Diabetes, Department of Medicine, Karolinska University Hospital, and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Stockholm, Sweden

* To whom correspondence should be addressed. E-mail: ivan.tancevski{at}i-med.ac.at.

The aim of the study was to investigate the influence of severe hyperthyroidism on plasma high-density lipoprotein cholesterol (HDL-C). Recently, it was shown in mice that increasing doses of triiodothyronine (T3) upregulate hepatic expression of scavenger receptor-BI (SR-BI), resulting in increased clearance of plasma HDL-C. Here we show that severe hyperthyroidism in mice did not affect hepatic expression of SR-BI, but reduced hepatic expression of ATP-binding cassette transporter 1 (ABCA1), accompanied by a 40%-reduction of HDL-C. Sterol content of bile, liver and feces was markedly increased, accompanied by upregulation of hepatic CYP7A1, and ATP-binding cassette half-transporter ABCG5, which is known to promote biliary sterol secretion upon dimerization with ABCG8. Both control and hyperthyroid mice exerted identical plasma clearance of intravenously injected [3H] HDL-C, supporting the view that severe hyperthyroidism does not affect HDL-C clearance, but rather its formation via hepatic ABCA1.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society